153.56MMarket Cap-6287P/E (TTM)
1.8800High1.8600Low7.49KVolume1.8600Open1.8500Pre Close14.05KTurnover0.01%Turnover RatioLossP/E (Static)81.68MShares3.290052wk High4.22P/B108.70MFloat Cap1.110052wk Low--Dividend TTM57.82MShs Float27.6000Historical High--Div YieldTTM1.08%Amplitude0.5300Historical Low1.8750Avg Price1Lot Size
ProQR Therapeutics Stock Forum
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...
1. $Viking Therapeutics (VKTX.US)$ closest competitor to $Madrigal Pharmaceuticals (MDGL.US)$ , which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1.
2. $ProQR Therapeutics (PRQR.US)$ announced collaboration with LLY, their RNAI editing softwa...
$AMC Entertainment (AMC.US)$ $AppTech Payments (APCX.US)$ $Core Scientific (CORZ.US)$ $iMedia Brands (IMBI.US)$ $CarMax (KMX.US)$ $Mersana Therapeutics (MRSN.US)$ $NVIDIA (NVDA.US)$ $Oric Pharmaceuticals (ORIC.US)$ $ProQR Therapeutics (PRQR.US)$ $Rocket Pharmaceuticals (RCKT.US)$ $Roku Inc (ROKU.US)$ $Cassava Sciences (SAVA.US)$ $Tesla (TSLA.US)$ $Expion360 (XPON.US)$
No comment yet